BMC Nephrology (2000) 1:1 http://biomed-central.com/1471-2369/1/1
	

 Survey/Cross sectional study
Early peri-operative hyperglycaemia and renal allograft rejection in 
patients without diabetes
	



	

	  !
"

 

#""	
 $%!&'(
#"")
!#!	*"+,	$%!&'(
#"-
")
!#!	*
&-
"
	(.
*/
0
*
	.**
,*!
*.**
,*!
	*	!.**
,*!

-
*	
.**
,*!
Abstract
Background: Patients with diabetes have an increased risk for allograft rejection, possibly related
to peri-operative hyperglycaemia. Hyperglycaemia is also common following transplantation in paï¿¾tients without diabetes. We hypothesise that exposure of allograft tissue to hyperglycaemia could
influence the risk for rejection in any patient with high sugars. To investigate the relationship of
peri-operative glucose control to acute rejection in renal transplant patients without diabetes, all
patients receiving their first cadaveric graft in a single center were surveyed and patients without
diabetes receiving cyclosporin-based immunosuppression were reviewed (n = 230). Records of the
plasma blood glucose concentration following surgery and transplant variables pertaining to alloï¿¾graft rejection were obtained. All variables suggestive of association were entered into multivariate
logistic regression analysis, their significance analysed and modeled.
Results: Hyperglycaemia (>8.0 mmol/L) occurs in over 73% of non-diabetic patients following surï¿¾gery. Glycaemic control immediately following renal transplantation independently predicted acute
rejection (Odds ratio=1.08). 42% of patients with a glucose < 8.0 mmol/L following surgery develï¿¾oped rejection compared to 71% of patients who had a serum glucose above this level. Hyperglyï¿¾caemia was not associated with any delay of graft function.
Conclusion: Hyperglycaemia is associated with an increased risk for allograft rejection. This is
consistent with similar findings in patients with diabetes. We hypothesise a causal link concordant
with epidemiological and in vitro evidence and propose further clinical research.
Background
	//

1

		-

23*#"1	
"("
,	"!/
 
	/23"!/

1  "	" 
-	   "(-

/* /""
	"
"(	/	"	41
	
	1	0/
253*
6,	/"/	("
///
	
/
		-
  
	1 	0/
    "(
	  
( 
1  /! 
/
 (
	-
	, 	/ " 
	1 	0/

273* 	
   !8! !
 	 ,
!(!""!(0/"

	-
//,	
*#/!	0/

!
(-
"   	 

	, 	
" ( 
	

(	


	11-

 "0!	*#/! 	/ 4
 
-
/ // 0!	 293  	
 2:3
Published: 4 October 2000
BMC Nephrology 2000, 1:1
The electronic version of this article is the complete one and can be found onï¿¾line at http://biomed-central.com/1471-2369/1/1
Received: 19 July 2000
Accepted: 18 September 2000

BMC Nephrology (2000) 1:1 http://biomed-central.com/1471-2369/1/1


 2;3 " ! 1
		

2<3*6
 =
!	
1
	1 ! 

	//
!"1!/	41
		0/



"((!,"!-
/
*!",	

1	-
-
	, 	/ 
 /! 	0/
  
	"(*
Methods
#		
/,	,"
1	/
	"1
	/

15:9
!"		1	/",	/
		>%!&'(

#""#!	(!	??"!	
*@			11!	"
!
	11!/

		1
"!
///
/

	=/!"" A9*#(""(/
	 
=/!"" A9" 	!""	
273*@
""
/			
	,"
-

1"((!
	8!	"!

	-
,	
"
	!(8!",
"

	
-
	"(!	
"""-
(/ 1
	  !	
 
1  !"* # >- 
/
//

	#/


	'
-
	 "B
	 	"

  	 	 !
-
!	
 
  
-
-	 ( 	
"1"A5"1
	"		!"	
!*
+  	

/
 2?3 //

	 # 9 B4B" 
"'
	<B4B"
!"'/

-
B"
	'
	B4B"	1	,

	:-<
!	1		
*&,		-
/,"	,
!(
!"

1
1	"-


	
	 
!		 "9 
  1



	*C>"
	/,

/

=/  4@ #D 9E 
	 

,
	-//	
-/	/,"
		"

-
5B"/
/"1	
"
1	
	
(

"*
	!(

"!/
"1

!		
		/
,	"1	!1	

1



		
("1	
(
	-

	 	/
	"* 	 	/
	" 	 
(" 1	
 
/

"(/!""

	 " "	 	-
/"	"	/(
""=4B
 
1 "//  "!	
 
1 
	

@ #4"/!		F#-#-"-> /*
@
-	
 	/
	" 
1  5  	
=" 1
	  	/ 
1 
	1 	0/
*#/!
	0/
"

//!	1(
-	
,
	//	-
0/

//!		"5"
1 	
*+1
(

	1
	" // 	0/
 		
-
/, "1" (  !" 	 ( 
	 
E1	
	"/"	!/		
,

"0!/,!
!	,	*
Statistical tests
#,	(/
"	" 
(	"/
	 
1 /!
	0/
		"
!,	
/		-

G(-,	(/	
!"*1!

" /
	
	" , /
	/ ,	( "

	
"		/"		/
1"'-

B!
1
		"

!
1'
	
	
/

  	/ 
1 "" 	1 1!/

	8!	"/
	"
'	
"/
!
!
,	("

		/(
""=4B
	"/
"//"!	

1
	-

"

	,!/
/
/	
"-
1

"


	1	!		*
F#/
/
"	"/
!
!,	-
(/
	"-:*
/
		1!
"*H	(	8!	
,"1	
 

"!4

"	
1//
,A*9*I!/
1
		/!	
-
	
1/
!
!,	(1
"
//4"	/!		"!
"
1
	 ( (
 		/ " 
-		/
*
	/J/!-
J
1/
!
!
,	(
		!'"=/
1
	1	
	"		/
*
"	1
	/-
"!"/
1/(	

	-F	

Ï‡D*""/	
	!"		-
/,	
	/!	, C/!	,//("/	-

 	 D *;* 
1"/ 	, 1
	  1

"	/
!"!(

	
"
(/
		/""//	"*		
11-

"	"	4	
	'"-
	
"(
1"
4
/
		/
 
"" 	
		
 !"	 /
"
 
1 /
-

 	,/ DE   !" 
!
* $-
,		!	=	"K?9E/
1"/	-
,* )L / 
1	,	
 :* ???
!"*
Results
Demographics

!"	""		(

"(/

1"
"	/,"//

	-("
!
!	
 1

 !//1! 	-

*#5		,"!"*

1	/77*;K*;	":E
1-
	*;E
1	#!	(
	-
*"

	5:*5K*	*F#
/*7K*"/*?K**<
E
1	""	1
		/,"
	
	"

 1	
 " 
* 55E 	/,"/

-
":;E	/,"'
	*
Hyperglycaemia
(

"!/
/
/	
"1	
!		*;9K*9:
BF"?*?
BF
	9*-9*:
BF*(

"!/
/
-

BMC Nephrology (2000) 1:1 http://biomed-central.com/1471-2369/1/1
/	
41


	A*5K
*9 
!	 	 ;-: 
!	 1	 !		  ?*57 K
*75
BF"<*:"<*K*5
BF


	
1"-*#!/
/
/	

1		
<*
BF	;5E
1
!	
!"
	5E,!/
		
* 
BF" 1	 !		* 9E 
1  -
"!/
,		<*
BF(

1	 !		 " 
  1

 
	*  /-
"/
1	/"
	

	-
-
	, !/
 , //  "!	
 
1

	
"

	
	*+""

!

1	-
	,
	

	,"=	

!
	-
/,"(""
1!//"/
1-
	/*///
	
"1


!		 /
		"  /
	
 
 !(8! "
 A*;:*
Acute rejection
#/!	0/

//!		"7;:7E
,	
 
1<*K*<" 1	 	
*<<-
:E"(
-	
,	0/
""9?-
 7E " // 	0/
 
! (

/
1	
*)=,	(""	"/"-

	1	0/
/!""

	
!!
1'-

	 
,	 /

 F#-/ " 
	/
1""	11!/
(*)

 ,	 /
		"  	0/
   !"
	
((	!
1=/!,!
1
		
"
	
!*+""
	!!/
"1
-

		
""
/-
"  /! 	0/
* I! 
" 
	-
F
Ï‡A7*?5A*;:	!"	 C/!	,
A *;9 

	 ?9E /
1"/ 	, *;-*<*
	
(	!!/
"	
(-
(
1	0/
!"
(	*
,	
=
 
1 	 	"! 
 !"  
-
	 	
*  
	 
1  	
 
"1"!
-	
	
=-",-
()/
1	 23*
	 1!/-

  !(8! !" 
 	  	 
1
	
((
1	0/
,	!!/
/
/	
!-
1	/


	
!1*
-
1/	/
(!/
,"!

1 	"

B
 A* 4

" 	

/
	
	"

"1*	-
/

(
("
	"!"11	

	 *!/
,"-
1

!			?*<K*;<
BF

! 	0/
 " *< K *9; 
BF  
 	0/
* 7E 
1    !/
 M <*

BF 1

 !		 ",
" 	0/
 /
-
	"
;E
1
"	!!/
(
,
,*6		/

	-
1	!		
	"/"	0/
""

11	
(	"/	
	/
	" 
 "-
1

!		*
Discussion
	//

1

	

	"(*;5E
1
!	!"
",
"	/D<*
BF1

!	-
	/	"(
"-
!	9E
1*
	1!	,
/"J!	/
	-"(J /	/	" ( 	" !/
 
	-
/!	/"	!23*+"-
"
 "	" 	-	  
"(
/* 
-"(/ 	 	/ 

		"	
"
!	//
-
	( 
 "(/  23* #
!  

!	!"	/,"	"

1	"-


	"	
1//	
*
	,
1!

19E"=	
//!
	/   
-"(/  
 	
"
23(!!
1	-
	,
		-
	,"=-
	
 "" 
 /
		  (

" !	 ,  
!	
!"* /

	# 
 11/! 	/
253
!!4 
!"
!",	/,"!11///

	
	
-
Table1
Model predictors for allograft rejection
Variable Risk ratio Standard Error P>|z| 95% confidence limits
Age (years) 0.993 0.002 0.009 .9894094 .9985157
Immediate graft function 0.782 0.101 0.060 .6065589 1.009974
Azathioprine/MMF 1.159 0.118 0.147 .9493317 1.416481
PRA> 50% + Prednisolone 0.595 0.104 0.003 .4221672 .8384729
Number of HLA-matches 0.944 0.023 0.016 .9004449 .9894315
Glucose (mmol/L) 1.015 0.004 0.000 1.008164 1.022061

BMC Nephrology (2000) 1:1 http://biomed-central.com/1471-2369/1/1
"!/	/
	1

	-

*
Figure 1
Fractional polynomial showing the probability of rejection in 
sensitised and un-sensitised CD1 patients versus the immediï¿¾ate post operative glucose level.
Figure 2
Fractional polynomial showing the probability of rejection in 
sensitised and un-sensitised CD1 patients versus the immediï¿¾ate post operative glucose level incorporating the interaction 
term.
)
,!"	/  -


 /   	4	 1
	 
	 =,
	-
	,!273*
,	(

"!/
,

!	!"""
/
			-
	,(

"

"!	

1
	

	/
"//*+


(
	=,	""

  		 	 N	O 
	
* )
 !"

/	"1	/
,
/
		
(
=
1//0!	"!/
,273*
-
,	 "/ 
1 
	1 1!/
 "" 
 /
		
!	,
!	!"*
#!	"P">"	
		#P>##	
	"		
"(,
	/!	0/
253*6
, 	,
! "
	"  
 
"(
	/,/"
	0/
	273*6	
		1
	1	
	-
	,	/

/"
/	" 	4 
1 
	1 	0/
	
"(* @  	-
	, 	/
" 1/ 
	 	0/
  
 
 	-
"!//*#/!	0/

!
(-
"   	 
-
	, 	
" ( 
	1
0!	"1
		

0!	*6

 	 	/ "	/-
/		4
1
	1	0/
(

1	(	
"
/*
!	,=/	(	//
"	!!0!	/		
1
		0/
*+4
	/
	
	//0!	=	
"293!-
"	/	
1
	!/
*	

1/
"	/,
=/	!"(/!-
	/ " 	-	1!
 0!	  
 ( -
/	" 293* !	, "	/,
/
	/
	
11/
-"(/	,2:3*"	!-
"
"1!/
	
!	-

	
="
1
	
"	
4@Q/,
2;3*+
""
!	
,	
-/
!1-
1/2;3*#
!
	
(!/
,
" "" 	1 1!/
  
(	,"  
!	 !"

!",
/"/
1""	1
1!/

(/	""(2<3*#
 
1 	,! "1// * 	/

	!	"!/"!/
!4"/	"

//!"
	

1

=/1/"273*	
"!
1!-
	//
	,//0!-
	 1

 
/	" 1	/
* 
,	 

  	 1!	 	 	!/* +
!4,
1	!		"-

1	/
!"("8!
!	

	1!*

  	
 " /
-!
 	
/	"  	/*  =	
 
1 
/+"/++

	1/	!-	-
!"(!/
-"!/"/B		1!
0!	
"
=",	2?3*	
"!/

1/
4
"!/ =	
 
1  	/	"
2<3"  !	
 
	1	
--
/" (  	/ 
1  !/
 /
/	

2:3* /,
=/
"(	/-
	/(
1/,		""	//
23* #

 
 /" ( 	/ 2;3
/	-	1!
-"!/"1
"-

BMC Nephrology (2000) 1:1 http://biomed-central.com/1471-2369/1/1
!0!	23/	

23&=	

1/
-!
	
/!	!-	-
!""	/(	/2<53""	/
( !/
-/" / 273 " 
=",
	293*

	/"!/=	"1-

		

/B		1!
"	0/

2<3*/!	
/	"(!"-
1// 273* @	
"!/
 
1 !/	 1/
	 4 
I4/"	/
1!/
,
273" 
 !-	!
 
1 (
 /!	 " !-

	11/
	
11
*&=	

1"


/!/!"+#-"H&I	/	"(
	/ 2:3* + ""
/	"=	


1><H#-&-/2;3"

	-

 
1@#- 2<3/
( 
/  "

"	-"
	

1

/* /,

=/	"	/"

"!/
 
1 	
1
	 /
4 2?3 " (

	
"!/
"/,
1/
4/!"
I-Î± "	1	
- 2:3(/"(
!/
,*#!"	
"!/

1IÎ²-
	/
!		
"!/

1+F-
253*
	4" 	/ 1

 	
" " !		

!	/
1!	/-
"	
*  (
/ ! 
 / 	1 !

!"(=
"/	/	"(	-

""	!"/	",-
 
1 /	/! ",/" /
 "-	
"!/
#&I- +F- +F-: " +F-*2553
/(,
	/
(
-
	/
!-	!
	10!	
		0/
*
@!	/"	


-
(
	
1!/!"-
  !" /
4 	
,  
	"
 
 	0/
 253*# 	/ !" 

 	-	 	! -	/, 	
  @ 
	/
"	4	
11
		
,

""	"/
	1	0/
2553*@	-
-
	, 	/ /
!" 	1
	 "1 !/

-	
,  
! ( /!* # 

!"((		
1!
-
	*
,	1/(	!	/
	
	-
"!/"	0/
	"(
	-
!(  ,  ! ! 
	/
	0!	4	
1
//!
"(/*+""

	-	,/-
//
	
	"	!
	'

1!
1!/
"	4	
11
2573*
@
		!""!(
 	0/
   
 "
!( 	*  
/
  
	 !(" 
	4 2?3*  	"!/"
	
(( 
1 	0/
   
 	/," 
	
	
"  	" 
 ( 	 
 
,	  !/
, I *  (  11/
(

1	,!(	
1,	
!/
,"
1
!	
"	-
*	/

"
	"!"11	-
 
	* 
,	 1 	   
 
!"	/
	"1
	
	
!
	
	//
,/	"	41
	

	1	0/
*
Conclusions
 " 	,
! !" ( ! , 
  -
  	 	/ 	 "(/ 
	

,/	"	41
	
	1	0/
*6
	/

	41
	
	1	0/

(
/

"!/(
	,-

* 	 	 
!" 	
  !	 
!" (
 /
	
" 1

 	
  
"(*I!		(,	,

1	
	/"

!	/

	,
	"!/
	10!	""/		0/-

 
" 	 
 I!		 	-
	/""
"	1!/	,
/
	
,	
!/
*
References
1. Pourmand G, Ebrahimi MR, Mehrsai AR, Taheri M: Patient blood
glucose levels before and after kidney transplantation Transï¿¾plant Proc, 2000, 32 (3):566-568
2. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek
E, Ritz E: Insulin resistance and hyperinsulinemia are already
present in patients with incipient renal disease. Kidney Int. 1998
May, 53(5):1343-1347
3. Australia and New Zealand Dialysis and Transplant Registry. : ANZï¿¾DATA Registry Report 1999. (Edited by Disney APS, Russ
GR, Walker R, Sheil AGR, Collins J, Herbert K, Kerr P). Adï¿¾elaide, South Australia. 1999, 
4. Thomas MC, Mathew TH, Russ GR, Rao MM: Peri-operative hyï¿¾perglycaemia and increased allograft rejection following reï¿¾nal transplantation in patients with diabetes (abstract) Kid Int
2000, 
5. Podrazik RM, Natale JE, Zelenock GB, Dâ€™Alecy LG: Hyperglycaeï¿¾mia exacerbates and insulin fails to protect in acute renal isï¿¾chaemia in the rat. J Surg Res 1989 Jun, 46(6):572-578
6. Pavlovic D, van de Winkel M, van der Auwera B, Chen MC, Schuit F,
Bouwens L, Pipeleers D: Effect of interferon-gamma and gluï¿¾cose on major histo-compatibility complex class I and class II
expression by pancreatic beta- and non-beta-cells J Clin Endoï¿¾crinol Metab 1997 Jul, 82(7):2329-2336
7. Min C, Kang E, Yu SH, Shinn SH, Kim YS: Advanced glycation end
products induce apoptosis and pro-coagulant activity in culï¿¾tured human umbilical vein endothelial cells. Diabetes Res Clin
Pract. 1999 Dec, 46(3):197-202
8. Panes J, Kurose I, Rodrigez-Vaca D, Anderson DC, Miyasaka M, Tso
P, Granger DN: Diabetes exacerbates inflammatory responses
to ischaemia-reperfusion. Circulation 1996, 93:161-167
9. Elias TJ, Bannister KM, Clarkson AR, Russ GR, Mathew TH, Barratt
LJ, Faull RJ: Excellent long-term graft survival in low risk, priï¿¾mary renal allografts treated with prednisolone-avoidance
immunosuppression. Clin Transplant. 2000 Apr, 14(2):157-161
10. Roysten P, Ambler GG: Sg112: Non-linear regression models
involving power or exponential functions of co-variates. In
The Stata Technical Bulletin Reprint, v9. Newton HJ. College Station; Tx:
Stata Corporation 1999, 173-180

BMC Nephrology (2000) 1:1 http://biomed-central.com/1471-2369/1/1
11. Ekstrand AV: Effect of steroid therapy on insulin sensitivity in
insulin-dependent diabetic patients after kidney transplantaï¿¾tion. J Diabet.Complications. 1991 Oct-Dec, 5(4):244-248
12. Chee YC: Blood glucose levels in non-diabetics on intraveï¿¾nous dextrose infusions. Ann Acad Med Singapore 1985 Apr,
14(2):294-296
13. Kutkuhn B, Hollenbeck M, Heering P, Koch M, Voiculescu A, Reinï¿¾hard T, Grabensee B: Development of insulin resistance and elï¿¾evated blood pressure during therapy with cyclosporine A.
Blood Press. 1997 Jan, 6(1):13-17
14. Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaeï¿¾mia and increased risk of death after myocardial infarction in
patients with and without diabetes: a systematic overview.
Lancet. 2000 Mar 4, 355(9206):773-778
15. Ceriello A: Acute hyperglycaemia and oxidative stress generï¿¾ation. Diabet Med 1997, 14(suppl3):S45-9
16. Walczyk MH, Pulliam J, Bennett WM: Effects of hyperglycaemia
and mannitol infusions on renal hemodynamics in normal
subjects. Am J Med Sci 1990 Oct, 300(4):218-224
17. Akbari CM, Saouaf R, Barnhill DF, Newman PA, LoGerfo FW, Veves
: Endothelium-dependent vasodilatation is impaired in both
microcirculation and macrocirculation during acute hypergï¿¾lycaemia. J Vasc Surg 1998 Oct, 28(4):687-694
18. Troppmann C, Gillingham KJ, Benedetti E, Almond PS, Gruessner
RW, Najarian JS, Matas AJ: Delayed graft function, acute rejecï¿¾tion, and outcome after cadaver renal transplantation. The
multivariate analysis. Transplantation 1995 Apr 15, 59(7):962-968
19. Goes N, Urmson J, Ramassar V, Halloran PF: Ischaemic acute tuï¿¾bular necrosis induces an extensive local cytokine response.
Evidence for induction of interferon-gamma, transforming
growth factor-beta 1, granulocyte-macrophage colony-stimï¿¾ulating factor, interleukin-2, and interleukin-10. Transplantation
1995 Feb 27, 59(4):565-572
20. Ratault K, Alderman C, Chain BM, Katz DR: Reactive oxygen speï¿¾cies activate human peripheral blood dendritic cells. Free Radï¿¾ic Biol Med 1999, 26(1-2):232-238
21. Daemen MARC, Veer CV, Denecker G, Heemskerk VH, Wolfs
TGAM, et al: Inhibition of apoptosis by ischaemia-reperfusion
prevents inflammation J Clin Invest 1999, 104:541-549
22. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M: Ricciarï¿¾di-Castagnoli P, Rugarli C, Manfredi AA Bystander apoptosis
triggers dendritic cell maturation and antigen-presenting
function. J Immunol 1998 Nov 1, 161(9):4467-4471
23. Moriatsu Takada, Anil Chandraker, Kari C Nadeau, Mohamed H
Sayegh, Nicholas L: Tilney The role of the B7 co-stimulatory
Pathway in Experimental Cold ischaemia/reperfusion injury.
J. Clin. Invest. 1997, 100(5):1199-1203
24. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R: Hyperglyï¿¾caemia-induced activation of nuclear transcription factor kaï¿¾ppaB in vascular smooth muscle cells. Diabetes1 1999 Apr,
48(4):855-864
25. Temaru R, Urakaze M, Satou A, Yamazaki K, Nakamura N, Kobayashi
M: High glucose enhances the gene expression of interleukinï¿¾8 in human endothelial cells, but not in smooth muscle cells:
possible role of interleukin-8 in diabetic macroangiopathy.
Diabetologia 1997 May, 40(5):610-616
26. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi
M, Remuzzi A, Zoja C, Remuzzi G: Leucocyte-endothelial interï¿¾action is augmented by high glucose in an NF-kB-dependent
fashion. J. Clin. Invest. 1998, 101:1905-1915
27. Takami S, Yamashita S, Kihara S, Kameda-Takemura K, Matsuzawa Y:
High concentration of glucose induces expression of interï¿¾cellular adhesion molecules-1 in human umbilical vein enï¿¾dothelial cells. Atherosclerosis. 1998, 138(1):35-41
28. Rattan V, Shen Y, Sultana C, Kumar D, Kalra VK: Glucose-induced
transmigration of monocytes is linked to phosphorylation of
PECAM-1 in cultured endothelial cells. Am J Physiol 1996 Oct,
271(4 Pt 1):E711-7
29. Manduteanu I, Voinea M, Serban G, Simionescu M: High glucose inï¿¾duces enhanced monocyte adhesion to valvular endothelial
cells via a mechanism involving ICAM-1, VCAM-1 and CD18
Endothelium 1999, 6(4):315-324
30. Reinhold D, Ansorge S, Schleicher ED: Elevated glucose levels
stimulate transforming growth factor-beta 1 (TGF-beta 1),
suppress interleukin IL-2, IL-6 and IL-10 production and
DNA synthesis in peripheral blood mononuclear cells. Horm
Metab Res 1996 Jun, 28(6):267-270
31. Hanson LA, Padyukov L, Strandvik B, Wramner L: The immune sysï¿¾tem of the hunter-gatherer meets poverty and excess. Lakarï¿¾tidningen. 2000 Apr 12, 97(15):1823-1826
32. Fernandez-Real JM, Ricart W: Insulin resistance and inflammaï¿¾tion in an evolutionary perspective: the contribution of cyï¿¾tokine genotype/phenotype to thriftiness. Diabetologia. 1999
Nov, 42(11):1367-1374
33. Perez RV, Brown DJ, Katznelson SA, Dubin JA, Muller HG, Chang T,
Rudich SM, McVicar JP, Kaysen GA: Pre-transplant systemic inï¿¾flammation and acute rejection after renal transplantation.
Transplantation 2000 Mar 15, 69(5):869-874
34. Albertini JP, Valensi P, Lormeau B, Aurousseau MH, Ferriere F, Attali
JR, Gattegno L: Elevated concentrations of soluble E-selectin
and vascular cell adhesion molecule-1 in NIDDM. Effect of inï¿¾tensive insulin treatment. Diabetes Care. 1998 Jun, 21(6):1008-
1013

